BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 24891169)

  • 1. Update on differentiated thyroid cancer staging.
    Momesso DP; Tuttle RM
    Endocrinol Metab Clin North Am; 2014 Jun; 43(2):401-21. PubMed ID: 24891169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implications of prognostic factors and risk groups in the management of differentiated thyroid cancer.
    Shaha AR
    Laryngoscope; 2004 Mar; 114(3):393-402. PubMed ID: 15091208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk stratification in medullary thyroid cancer: moving beyond static anatomic staging.
    Tuttle RM; Ganly I
    Oral Oncol; 2013 Jul; 49(7):695-701. PubMed ID: 23601563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contemporary post surgical management of differentiated thyroid carcinoma.
    Tala H; Tuttle RM
    Clin Oncol (R Coll Radiol); 2010 Aug; 22(6):419-29. PubMed ID: 20605708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spontaneous remission in thyroid cancer patients after biochemical incomplete response to initial therapy.
    Vaisman F; Momesso D; Bulzico DA; Pessoa CH; Dias F; Corbo R; Vaisman M; Tuttle RM
    Clin Endocrinol (Oxf); 2012 Jul; 77(1):132-8. PubMed ID: 22248037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Response to initial therapy predicts clinical outcomes in medullary thyroid cancer.
    Lindsey SC; Ganly I; Palmer F; Tuttle RM
    Thyroid; 2015 Feb; 25(2):242-9. PubMed ID: 25338223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Consensus conference on well-differentiated thyroid cancer: a summary.
    Pasieka JL; Rotstein LE
    Can J Surg; 1993 Aug; 36(4):298-301. PubMed ID: 8370008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic factors and the therapeutic strategy for patients with bone metastasis from differentiated thyroid carcinoma.
    Orita Y; Sugitani I; Matsuura M; Ushijima M; Tsukahara K; Fujimoto Y; Kawabata K
    Surgery; 2010 Mar; 147(3):424-31. PubMed ID: 20176243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical outcome of low-risk differentiated thyroid cancer patients after radioiodine remnant ablation and recombinant human thyroid-stimulating hormone preparation.
    Vianello F; Mazzarotto R; Mian C; Lora O; Saladini G; Servodio O; Basso M; Pennelli G; Pelizzo MR; Sotti G
    Clin Oncol (R Coll Radiol); 2012 Apr; 24(3):162-8. PubMed ID: 21411300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A model for predicting outcomes in patients with differentiated thyroid cancer and model performance in comparison with other classification systems.
    Yildirim E
    J Am Coll Surg; 2005 Mar; 200(3):378-92. PubMed ID: 15737848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High recurrent rate of multicentric papillary thyroid carcinoma.
    Lin JD; Chao TC; Hsueh C; Kuo SF
    Ann Surg Oncol; 2009 Sep; 16(9):2609-16. PubMed ID: 19533244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of thyroid tumor aggressiveness.
    Clark OH
    West J Med; 1996 Sep; 165(3):131-8. PubMed ID: 8909165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic factors in well-differentiated thyroid carcinoma in patients treated and followed in the same institution.
    Cappelli C; Pirola I; Braga M; De Martino E; Morassi ML; Gandossi E; Mattanza C; Balzano R; Castellano M; Rosei EA
    Ann Ital Chir; 2006; 77(2):107-13. PubMed ID: 17147082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of surgery, radioiodine, and external radiation therapy on the clinical outcome of patients with differentiated thyroid carcinoma.
    Tsang RW; Brierley JD; Simpson WJ; Panzarella T; Gospodarowicz MK; Sutcliffe SB
    Cancer; 1998 Jan; 82(2):375-88. PubMed ID: 9445196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differentiated thyroid cancer in children: diagnosis and management.
    Dinauer CA; Breuer C; Rivkees SA
    Curr Opin Oncol; 2008 Jan; 20(1):59-65. PubMed ID: 18043257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Total thyroidectomy followed by postsurgical remnant ablation may improve cancer specific survival in differentiated thyroid carcinoma.
    Doi SA; Engel JM; Onitilo AA
    Clin Nucl Med; 2010 Jun; 35(6):396-9. PubMed ID: 20479583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Total thyroidectomy for differentiated thyroid cancer.
    Sosa JA; Udelsman R
    J Surg Oncol; 2006 Dec; 94(8):701-7. PubMed ID: 17131393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The significance of the AMES and the NTM systems to determine the prognosis in patients with differentiated cancer of the thyroid].
    GarcĂ­a de Paredes G
    Rev Med Panama; 1992 Sep; 17(3):155-62. PubMed ID: 1439000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conservative management of patients with intrathyroidal well-differentiated follicular thyroid carcinoma.
    Saadi H; Kleidermacher P; Esselstyn C
    Surgery; 2001 Jul; 130(1):30-5. PubMed ID: 11436009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Operative strategy for follicular thyroid cancer in risk groups stratified by pTNM staging.
    Lin JD; Chao TC; Chen ST; Huang YY; Liou MJ; Hsueh C
    Surg Oncol; 2007 Aug; 16(2):107-13. PubMed ID: 17600699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.